Food and Drug Regulations

C.08.009.04 Sections A.01.040 and C.01.004.1, subsection C.01A.004(1), section C.01A.006 and Divisions 2 to 4, other than the following provisions, do not apply in respect of the importation, under section C.08.009.03, of a designated COVID-19 drug by the holder of an establishment licence:

• (a) sections C.02.003.1, C.02.004 and C.02.006, as they apply to the storage of the designated COVID-19 drug by the holder;

• (b) subsection C.02.012(1);

• (c) sections C.02.013 and C.02.014;

• (d) section C.02.015, as it applies to the storage and transportation of the designated COVID-19 drug by the holder;

• (e) subsection C.02.021(1), as it applies to the storage of the designated COVID-19 drug by the holder;

• (f) subsection C.02.022(1);

• (g) section C.02.023;

• (h) subsection C.02.024(1);

• (i) section C.03.013; and

• (j) section C.04.001.1, as it applies to the storage of the designated COVID-19 drug by the holder.